Implanet SA (ALIMP) - Total Assets
Based on the latest financial reports, Implanet SA (ALIMP) holds total assets worth €16.53 Million EUR (≈ $19.33 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See ALIMP total equity for net asset value and shareholders' equity analysis.
Implanet SA - Total Assets Trend (2010–2024)
This chart illustrates how Implanet SA's total assets have evolved over time, based on quarterly financial data.
Implanet SA - Asset Composition Analysis
Current Asset Composition (December 2024)
Implanet SA's total assets of €16.53 Million consist of 69.3% current assets and 30.7% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 10.8% |
| Accounts Receivable | €3.01 Million | 20.2% |
| Inventory | €5.64 Million | 37.9% |
| Property, Plant & Equipment | €1.59 Million | 10.7% |
| Intangible Assets | €2.78 Million | 18.7% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2010–2024)
This chart illustrates how Implanet SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ALIMP market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Implanet SA's current assets represent 69.3% of total assets in 2024, an increase from 0.0% in 2010.
- Cash Position: Cash and equivalents constituted 10.8% of total assets in 2024, up from 9.2% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 18.0% of total assets, an increase from 0.0% in 2010.
- Asset Diversification: The largest asset category is inventory at 37.9% of total assets.
Implanet SA Competitors by Total Assets
Key competitors of Implanet SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.15 Billion |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607
|
China | CN¥988.48 Million |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
|
USA | $139.92 Million |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO
|
India | Rs8.57 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
|
Aligned Genetics Inc
KQ:238120
|
Korea | ₩45.11 Billion |
|
Heramed Ltd
AU:HMD
|
Australia | AU$1.04 Million |
|
Acarix A/S
ST:ACARIX
|
Sweden | Skr48.33 Million |
Implanet SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.72 | 1.17 | 1.28 |
| Quick Ratio | 0.25 | 0.59 | 0.56 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-4.66 Million | €1.37 Million | €1.36 Million |
Implanet SA - Advanced Valuation Insights
This section examines the relationship between Implanet SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.15 |
| Latest Market Cap to Assets Ratio | 2.21 |
| Asset Growth Rate (YoY) | 40.0% |
| Total Assets | €14.89 Million |
| Market Capitalization | $32.93 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Implanet SA's assets at a significant premium (2.21x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Implanet SA's assets grew by 40.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Implanet SA (2010–2024)
The table below shows the annual total assets of Implanet SA from 2010 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €14.89 Million ≈ $17.41 Million |
+39.98% |
| 2023-12-31 | €10.64 Million ≈ $12.44 Million |
-26.51% |
| 2022-12-31 | €14.47 Million ≈ $16.92 Million |
-13.34% |
| 2021-12-31 | €16.70 Million ≈ $19.53 Million |
+91.96% |
| 2020-12-31 | €8.70 Million ≈ $10.17 Million |
-9.82% |
| 2019-12-31 | €9.65 Million ≈ $11.28 Million |
+9.04% |
| 2018-12-31 | €8.85 Million ≈ $10.35 Million |
-29.56% |
| 2017-12-31 | €12.56 Million ≈ $14.69 Million |
-23.67% |
| 2016-12-31 | €16.46 Million ≈ $19.24 Million |
+1.03% |
| 2015-12-31 | €16.29 Million ≈ $19.04 Million |
+11.92% |
| 2014-12-31 | €14.55 Million ≈ $17.02 Million |
-39.16% |
| 2013-12-31 | €23.92 Million ≈ $27.97 Million |
+103.23% |
| 2012-12-31 | €11.77 Million ≈ $13.76 Million |
-29.58% |
| 2011-12-31 | €16.72 Million ≈ $19.54 Million |
+42.02% |
| 2010-12-31 | €11.77 Million ≈ $13.76 Million |
-- |
About Implanet SA
Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fix… Read more